Applicability:
The freeze-sensitive tracer vaccine is transported in insulated containers (for vaccine distribution or collection).
Scoring:
0: Staff state that ice-packs packs are packed with the freeze-sensitive tracer vaccine, or they are observed to do so.
1: Otherwise.
PG: -
PR: 5
SN: 5
LD: 5
SP: 5
R0277 - Responsible staff are knowledgeable of key principles and procedures of vaccine transportation.
1.15
Title | Description | Author | Published | Sample type |
---|---|---|---|---|
Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine | This document includes key vaccine specific information on the vaccine specific requirements for Sinovac CoronaVac® [Vero Cell] vaccine. | World Health Organization | 2021 | Guidance |
AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine | The document includes key information on the vaccine specific requirements. | Oxford University; AstraZeneca | 2021 | Guidance |
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine | This document includes key vaccine specific information on the vaccine specific requirements for Sinopharm [Vero Cell] vaccine. | World Health Organization | 2022 | Guidance |
EVM Model Standard Operating Procedures Consolidated version, with user guide | This SOP explains how to verify that the vaccines delivered are in good condition and that they are accompanied by the appropriate documents before accepting them in the national supply chain | World Health Organization | 2013 | Guidance |
Janssen Ad26.COV2-S [recombinant], COVID-19 vaccine | This document includes key information on the vaccine specific requirements for the Janssen Ad26.COV2-S vaccine. | World Health Organization | 2022 | Guidance |
NVX-CoV2373 recombinant, adjuvanted COVID-19 vaccine | This document includes key vaccine specific information on the vaccine specific requirements for Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine. | World Health Organization | 2022 | Guidance |
Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran) | This training provides information on characteristics of different formulations of Pfizer-BioNTech COVID-19 vaccine, storage and transport requirements, procedures for effective management during storage, transport and use. It also includes guidance for establishing an ultra-cold chain system. It is recommended to select the appropriate slides/modules based on the training needs and profile of the participants. | World Health Organization | 2023 | Training |
COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine | This document outlines important information for the COVID-19 Vaccine COVAXIN® (BBV152) vaccine. | World Health Organization | 2022 | Guidance |